GLP1 agonist
Clinical trials for GLP1 agonist explained in plain language.
Never miss a new study
Get alerted when new GLP1 agonist trials appear
Sign up with your email to follow new studies for GLP1 agonist, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Muscle-Saving app: a new weapon in the GLP-1 weight loss battle?
Disease control Not yet recruitingThis study tests a 12-week app-based strength training program called PLAN-RT 1.0, designed for midlife women (ages 40-54) who recently started GLP-1 medication for weight loss. The goal is to see if the program is practical and acceptable, and whether it can help preserve muscle…
Matched conditions: GLP1 AGONIST
Sponsor: Louisiana State University and A&M College • Aim: Disease control
Last updated Aug 28, 2026 00:00 UTC
-
Could a Weight-Loss drug ease chronic back pain? a trial investigates
Symptom relief Not yet recruitingThis phase 2 trial tests whether semaglutide, a weekly injection already used for weight loss, can reduce chronic low back pain in adults with obesity. Researchers will compare semaglutide to a placebo over 52 weeks in 250 participants, measuring changes in pain severity, disabil…
Matched conditions: GLP1 AGONIST
Phase 2 • Sponsor: Washington University School of Medicine • Aim: Symptom relief
Last updated Jul 30, 2026 00:00 UTC
-
Weight loss showdown: GLP-1 drugs vs. surgery for pelvic floor health
Knowledge-focused Not yet recruitingThis study will follow 200 women who are either taking GLP-1 weight loss drugs or undergoing bariatric surgery. Researchers want to see how these treatments change pelvic floor symptoms like incontinence and prolapse. Participants do not need to have any pelvic floor symptoms to …
Matched conditions: GLP1 AGONIST
Sponsor: Hartford HealthCare • Aim: Knowledge-focused
Last updated Jun 26, 2026 18:04 UTC